One of the country’s Top 10 wholesale distributors is selecting LSPediA Inc. to provide drug verification services under the 2019 saleable returns requirement of the Drug Supply Chain Security Act.
The wholesaler selected LSPediA’s VRS solution for its full functionality, including sub-second verification response time, exceptions management, industry expertise, and full compliance with the FDA regulations. The implementation is scheduled to start in July, with supplier on-boarding activities beginning in August.
Following the VRS implementation, the wholesaler plans to implement LSPediA’s EPCIS system for 2023 interoperability, offering serial capability to more than one thousand customers, including long-term care facilities, regional hospitals, and independent pharmacies.
About LSPediA – Life Sciences Solutions
LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA’s serialization solution RxChain enables pharmaceutical manufacturers, wholesale distributors, dispensers to manage data, distribute products, and track inventory at the serialized level. LSPediA’s Verification Router Service enables authorized trading partners to authenticate serialized products, verify returns, and deter counterfeiting.